Clinical Trial

Impact of Respiratory Allergy on Response to Initiation of Biotherapy in Severe Asthma in Adult Severe Asthmatic Patients Followed at Poitiers University Hospital on Biotherapy

Study acronym: IARBASP
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The aim of this study is to take stock of the situation of adult patients with severe asthma on biotherapy, followed up at Poitiers University Hospital, and in particular to increase our knowledge of factors predictive of response to biotherapy. The main aim is to improve the management of adult severe asthma patients treated with biotherapy, according to their allergic status.
Trial Details
NCT Number NCT06916104
Lead Sponsor Poitiers University Hospital
Conditions Severe Asthma, Biotherapy, Respiratory Allergy
Enrollment 100 participants
Start Date 2024-03-01
Primary Completion 2025-03-31 (estimated)
Study Completion 2025-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-08